HOW CAN WE FIX OUR EXISTING PATENT/IP LAWS

Slides:



Advertisements
Similar presentations
Impact of JUSFTA on affordability and availability of medicines from perspective of local generic manufacturers Towards equitable and affordable medicine.
Advertisements

WTO/WHO Workshop on Differential Pricing-8-11 April 2001 By Carlos M. Correa University of Buenos Aires.
1 WTO and medicines: from Doha to Cancún Germán Velásquez Essential Drugs and Medicines Policy World Health Organization Geneva, October 2003.
IP System and Economic Development: Empirical Evidence from China Qi Su IP Institute, Tong Ji University Dec 04, TongJi Global Intellectual Property.
RECOMMENDATIONS BY INTELLECTUAL PROPERTY LAWYERS ON LEGAL REFORM MOSES NKOMO LL.B, MIP.
China on the way to a high-technology country: The legal policy perspective Stefan Luginbuehl Lawyer, International Legal Affairs.
Possible Impact of Market Exclusivity Extension on Pharmaceuticals in Thailand Chutima Akaleephan International Health Policy Program, Thailand 27 August.
Challenges and Opportunities to Utilize TRIPS Flexibilities in Current Ukrainian Legislation: Potential Impact of IP Provisions in the Proposed EU FTA.
Intellectual Property, Free Trade Agreements and sustainable Development Hanan Sboul Secretary General/ The Jordanian Association of Pharmaceutical Manufacturers.
Intellectual Property Strategies For Development: Issues and Challenges WIPO Second Annual Conference on South-South Cooperation on Intellectual Property.
Presentation to Civil Society meeting Lusaka 1 October 2013.
Medicines & Related Substances Amendment Bill: Protecting the Nation’s Health “The State must take reasonable legislative and other measures, within its.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA AN OVERVIEW OF PATENT PROTECTION IN ZAMBIA.
AUDREY R. CHAPMAN, PH.D. UNIVERSITY OF CONNECTICUT HEALTH CENTER INTELLECTUAL PROPERTY AND HUMAN RIGHTS MEETING PANEL 1: IP AND HEALTH FEBRUARY 21, 2013.
Patent Related Flexibilities in the Pharmaceutical Field
Procurement of patented and other essential medicines: challenges and opportunities Wilbert Bannenberg, MD MPH Zambia TRIPS workshop.
IP Policy and its linkages with Economic, Science & Technology Policies Muhammad Ismail Deputy Director IPO-Pakistan October 09, 2013 IN THE NAME OF ALLAH,
PATENTS AND HEALTH. A CASE STUDY OF THE UGANDAN CONTEXT. (PHA3 JULY 7 TH 2012 –CAPE TOWN, SOUTH AFRICA) MS. MARIAM AKIROR LLB (HONS) / DIP. SW / CPC. PROG.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA PROPOSED PATENT BILL AND ITS RELEVANCY.
PATENTS, TRIPS AND ACCESS TO MEDICINES – a legal perspective
International IP Regime and A2M : Role of BRICS K M Gopakumar TWN.
What are those “trade related aspects” anyhow? Relocating IP in today’s WTO.
Patents, access to medicines and the WTO ’ s TRIPs Agreement Consultative meeting on incorporation of TRIPs Flexibilities Morogoro, Tanzania 24 July 2006.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA Anthony Bwembya, Registrar & CEO 2 nd October2013.
Ten Years of the Doha Declaration: The State of Implementation Geneva 14 November
Page 1 Implementation of the WTO Decision on TRIPS and Public Health Government of Canada August 2004.
The Doha Declaration and the Protocol amending the TRIPS Agreement Islamabad, 28 November 2007 Octavio Espinosa WIPO.
Trade Related Aspects of Intellectual Property Rights FAO Regional Workshop on WTO Accession Damascus, October 2008 Hamish Smith Agriculture and.
Technology Transfer and IP framework initiatives May 2011.
ACCESS TO MEDICINES - POLICY AND ISSUES
UNCTAD/CD-TFT 1 Exclusive Rights and Public Access – Flexibilities in International Agreements and Development Objectives The Public Health Example 21.
O VERVIEW OF P UBLIC H EALTH -R ELATED TRIPS F LEXIBILITIES Sisule F. Musungu, IQsensato (
© 2008 International Intellectual Property June 24, 2009 Class 8 Patents: Multilateral Agreements (WTO TRIPS); Global Problem of Patent Protection for.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA PROPOSED PATENT BILL AND ITS RELEVANCY.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN LESOTHO REPORT OF DAY 1 Botha Tiheli, Masello.
Presentation to Civil Society meeting Harare 21 January 2014.
Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies By Yvonne Nkrumah Legal Counsel, Ghana Food and Drugs Board.
The structure of an IP Institutional Policy “Ten Questions Method” Sofia, Bulgaria November 25 and 26, 2015.
DOMESTICATION OF TRIPS FLEXIBILITIES IN NATIONAL IP LEGISLATION FOR STRENGTHENING ACCESS TO MEDICINES IN ZAMBIA RECAP ON PROCEEDINGS OF DAY 1 George Mpundu.
A presentation by Moses Nkomo Intellectual Property Attorney and Consultant National Workshop on TRIPS and access to medicines in Zimbabwe Holiday Inn,
Preliminary classification of proposals by the CEWG Proposals for innovative financing: Discussing the work to-date of WHO’S Consultative Expert Working.
Implementation of TRIPS Flexibilities In National IP Legislation For Strengthening Access To Medicines In Swaziland Workshop with MOH and stakeholders,
Basic economic freedoms. 1. Free movement of goods The Community shall be based upon a customs union which shall cover all trade in goods and which shall.
South Africa’s Acceptance of the Protocol Amending the TRIPS Agreement Xolelwa Mlumbi- Peter DDG: ITED 24 November 2015.
Paris Convention §5A “(1) Importation by the patentee into the country where the patent has been granted of articles manufactured in any of the countries.
Durban, South Africa January 29 to 31, 2013 Topic 13: The Effective Administrative Process for the Grant of Compulsory Licenses Regional Seminar for Certain.
1 Bolar Provisions in Europe Robert Watson Chartered Patent Attorney European Patent Attorney AIPLA, February 2006.
1 Seminar on the Internal Market Acquis for the Eastern Partnership Countries Nevena Mateeva Unit D2 - Industrial Property Rights, Internal Market & Services.
Overview: The South African IP Policy Review 13 September 2012 MacDonald Netshitenzhe: Chief Director- Policy and Legislation.
Copyright Registration - The Steps To Protect Your Work.
Overview of presentation
Intellectual Property, Free Trade Agreements and sustainable Development Hanan Sboul Secretary General/ The Jordanian Association of Pharmaceutical Manufacturers.
Paris Convention §5A “(1) Importation by the patentee into the country where the patent has been granted of articles manufactured in any of the countries.
WTO and medicines: from Doha to Cancún
— Creative india, innovative indiA
Intellectual Property Protection and Access to Medicines
Making medicines, diagnostics and other commodities more affordable
Boğaziçi University, International Trade Department
FTAA and Access to Medicines
PATENTS, TRIPS, FLEXIBILITIES & ACCESS TO MEDICINES
WIPO NATIONAL SEMINAR ON INTELLECTUAL PROPERTY RIGHTS AND THE PROTECTION OF PHARMACEUTICAL PRODUCTS Damascus, April 25 and 26, 2005 Current issues on Intellectual.
Competition Education and Advocacy in Nepal
Sub-Regional Meeting for ASEAN Countries on the Marrakesh Treaty and the Production and Exchange of Accessible Books by the World Intellectual Property.
Implementation of TRIPS Flexibilities In National IP Legislation For Strengthening Access To Medicines In Swaziland Workshop with MOH and stakeholders,
Main findings and recommendations from the UNIDO study on the pharmaceutical sector in Zimbabwe Domestication of TRIPs Flexibilities in National IP Legislation.
IP Provisions in Bilateral & Regional Trade Agreements and Public Health ICTSD/QUNO Dinner Discussion on IPRs in Bilateral & Regional Trade Agreements.
MINISTRY OF JUSTICE, LEGAL & PARLIAMENTARY AFFAIRS
Acceptance of the Protocol Amending the TRIPS Agreement
Mika Lodge 2-3 October, 2013 Ministry of Commerce Trade and Industry
The BIS Act – Enabling USE of standards in technical regulations
Presentation transcript:

HOW CAN WE FIX OUR EXISTING PATENT/IP LAWS GROUP 3 HOW CAN WE FIX OUR EXISTING PATENT/IP LAWS

SUBMISSIONS Bolar exception should have no time limits to allow for registration of generics where the patented medicine expires. Need to prevent patenting medicines which have been found to have new uses e.g. Viagra which was used for cardiovascular conditions. Harmonisation of the Patents Act on parallel importation with the Medicines and Allied Substances Control Act. Strengthen the provisions on compulsory licencing so that we can benefit from CLs as and when we need to issue them, eg on grounds of public interest.

SUBMISSIONS There is need to ensure that the proposed IP policy is drafted in order to set out the main objectives for the IP legislation. The IP policy should look at how the country intends to benefit from the legislation. Policy should also focus on how to protect, reward and support people who discover inventions. It should also look at the national interest in terms of articles 7 and 8 of TRIPS.

SUBMISSIONS There is need for broad based stakeholder consultations on the draft IP policy. This can be done through radio and TV programs, publishing in newspapers, and targeting specific interest groups such as musicians, performers, R&D institutions, commerce and industry.

SUBMISSIONS Need to domesticate the protocol amending TRIPS allowing for compulsory licences to export to the region – article 31bis. Inclusion of a provision for research and experiments – where the State funds R&D at public institutions, the ensuing IP belongs to the R&D institution. A thorough review/audit of all IP laws to ensure that they conform the international best practices.